Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

DEfeating PEnile CAncer-2

NCT07378670 · University Hospital Tuebingen · Updated 30 Sept 2026

What is being tested
open inguinal lymphadenectomy; robot-assisted inguinal lymphadenectomy
For
Penile Cancer; Penile Neoplasms Malignant
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 80 people. The full rules are on the registry page.
Where
Germany (9 sites)
When
Starts or started 10 April 2026, ends 30 Nov 2031. Registered 30 Jan 2026.
Results
None posted yet.

In the researchers' words

Open inguinal lymphadenectomy (O-ILAD) is the current standard of care for invasive staging and simultaneously the curative approach for patients with PeCa and elevated risk for or clinically detectable lymphatic disease in the groin. The high rate of complications of this surgical procedure, which are often mutilating and associated with a long-term convalescence, leads to a critical delay in initiation of adjuvant systemic therapy. Being in apprehension of these postsurgical adversities, physicians are often reluctant with indicating this procedure, thus depriving their patients of the vital prognosis-relevant care. In the sum, these obstacles inevitably result in inferior oncologic outcomes. Aiming to decrease postsurgical detrimental sequelae, several attempts to modify radicality of the technique, including inter alia a radioguided approach of sentinel lymph node resection, have been presented in the last decades. Unfortunately, utilization of the sentinel lymph node technique outside of a few highly specialized referral centers is prone to a significant false negativity, while other approaches are associated with inconsistent oncological and perioperative outcomes, hence precluding a general breakthrough in the surgical management of the groin lymph nodes. Thus, a high unmet medical need exists for the establishment of an approach with the lowest possible rate of…
ClinicalTrials.gov, NCT07378670

Sites

  • Charité- Universitätsmedizin BerlinBerlin, Germany
  • University Hospital Carl Gustav CarusDresden, Germany
  • Universitätsklinikum ErlangenErlangen, Germany
  • University Medical Center of Johannes Gutenberg-UniversityMainz, Germany
  • Medical Faculty MannheimMannheim, Germany
  • Ludwig Maximilian University HospitalMünchen, Germany
  • University Medicine RostockRostock, Germany
  • University Hospital TübingenTübingen, Germany
  • University Hospital UlmUlm, Germany